Product NDC: | 55154-2475 |
Proprietary Name: | Ampicillin and Sulbactam |
Non Proprietary Name: | ampicillin sodium and sulbactam sodium |
Active Ingredient(s): | 1; .5 g/1; g/1 & nbsp; ampicillin sodium and sulbactam sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-2475 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065316 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070629 |
Package NDC: | 55154-2475-5 |
Package Description: | 5 INJECTION, POWDER, FOR SUSPENSION in 1 BAG (55154-2475-5) |
NDC Code | 55154-2475-5 |
Proprietary Name | Ampicillin and Sulbactam |
Package Description | 5 INJECTION, POWDER, FOR SUSPENSION in 1 BAG (55154-2475-5) |
Product NDC | 55154-2475 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ampicillin sodium and sulbactam sodium |
Dosage Form Name | INJECTION, POWDER, FOR SUSPENSION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20070629 |
Marketing Category Name | ANDA |
Labeler Name | Cardinal Health |
Substance Name | AMPICILLIN SODIUM; SULBACTAM SODIUM |
Strength Number | 1; .5 |
Strength Unit | g/1; g/1 |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC] |